Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-02-18
1999-11-02
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514342, 514362, 514372, 514367, 514368, 514373, 514381, 5462694, 546256, 5462687, A61K 3144, A61K 3141, A61K 31425, C07P41304
Patent
active
RE0363758
ABSTRACT:
The present invention relates to therapeutically active azacyclic compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
REFERENCES:
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
Mitch Charles H.
Olesen Preben H.
Sauerberg Per
Criares Theodore J.
Novo Nordisk A S
Rozek Carol E.
Zelson Steve T.
LandOfFree
Treatment of Alzheimer's disease using azacyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of Alzheimer's disease using azacyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Alzheimer's disease using azacyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2119429